Global phototherapy market was valued at USD 389.5 million
The market growth is being driven by the increasing adoption of LED-based phototherapy, greater awareness of skin diseases, and the introduction of advanced phototherapy equipment.
Phototherapy, also known as light therapy, uses Ultraviolet (UV) light to promote healing. It is widely used around the world to treat chronic skin conditions, such as eczema, vitiligo, and severe psoriasis. Unlike other medical treatments, which may have a general impact on the immune system, UV radiation can target the local immune system of the skin. Phototherapy can also delay the development of thick, scaly skin in conditions such as psoriasis, and increase the activation of melanocytes, which produce skin pigmentation. It is a preferred treatment option for those who prefer natural therapies, want to avoid steroids, or have more control over their treatment.
Phototherapy is an effective therapeutic treatment for many dermatological conditions and has a significant impact on their management. Non-ionizing radiation from the UV region of the electromagnetic spectrum is carefully administered to the skin, using a variety of techniques, such as Ultraviolet A (UVA), Ultraviolet A-1 (UVA-1), Psoralen-Ultraviolet A (PUVA), and Ultraviolet B (UVB) radiation, including Narrowband Ultraviolet B phototherapy (NB-UVB) or Broadband Ultraviolet B (BB-UVB) therapy.
Recently, on 22 August 2022, Sewon NC, based in Korea, announced its plans to launch Organic Light-emitting Diode (OLED)-based phototherapy solutions for pain management and skin conditions. The flexible OLED optical patch, developed by KAIST, is less than 1 mm thick and can be easily fastened to the body. The patches have produced positive results in preclinical experiments, and Sewon aims to expand their use to treat various skin conditions, such as wrinkles, skin cancer, dementia, and other skin disorders.
The increasing adoption of LED-based treatments is a major driver of revenue growth in the global phototherapy market. Phototherapy utilizes light radiation to treat physical or mental ailments, with cells and tissues responding differently depending on the wavelength and therapeutic dosage of the light. One key benefit of LED-based phototherapy is the increase in collagen levels in the skin, which can reduce the appearance of wrinkles and other signs of aging. LED light therapy can also be used to treat acne, dermatitis, eczema, psoriasis, rosacea, scarring, and sun damage.
Additionally, LED light therapy has an antimicrobial effect that can effectively kill various types of bacteria that contribute to breakouts by clogging pores and oil glands. In a study, LED phototherapy treatment improved acne in 77% of cases after five weeks. To drive further revenue growth of LED-based phototherapy, major companies are launching new and advanced technologies. For example, Elipsa, the latest LED light treatment from LightStim, seamlessly integrates with BeautyHealth's Syndeo next-generation HydraFacial system and is expected to experience exponential growth in 2022. The new LightStim Elipsa enhances treatment outcomes and the provider experience, and is now available for retail and business use in the United States, with plans for international expansion in partnership with Syndeo.
No comments: